Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Immuron Limited ( (AU:IMC) ).
Immuron Limited has announced a proposed issue of 135,800 fully paid ordinary securities, with the issuance date set for May 29, 2025. This move is part of a placement or other type of issue, potentially impacting the company’s market positioning by increasing its capital base and enhancing its financial flexibility.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases.
Average Trading Volume: 108,473
Technical Sentiment Signal: Sell
Current Market Cap: A$14.72M
For detailed information about IMC stock, go to TipRanks’ Stock Analysis page.